Abstract: Highly water-soluble, artificial glycopolypeptides with a γ-polyglutamic acid (γ-PGA) backbone derived from Bacillus subtilis and multivalent sialyloligosaccharide units have been chemoenzymatically synthesized as potential polymeric inhibitors of infection by influenza virus. 5-Trifluoroacetamidopentyl β-Nacetyllactosaminide (1) was enzymatically synthesized from N -acetyllactosamine (LacNAc: Galβ1-4GlcNAc) by cellulase-mediated condensation with 5-trifluoroacetamido-1-pentanol. Next, enzymatic sugar elongation of the LacNAc unit to 1 was carried out by consecutive use of β1,3-N -acetylglucosaminyltransferase II (β3GnTII) and β1,4-galactosyltransferase I (β4GalTI) to produce tetra-and hexasaccharide glycosides (2 and 3) with tandem and triplet LacNAc repeats. After deacetylation, the resulting 5-aminopentyl di-, tetra-and hexasaccharide glycosides (4-6) were coupled to the α-carboxy groups of the γ-PGA side chains. Next, in order to synthesize an artificial sialoglycopolypeptide, we developed a large-scale production of rat α2,6-sialyltransferases (α2,6-SiaT). The α2,6-SiaT was expressed in fifth instar silkworm larval hemolymph using recombinant both cysteine protease-and chitinase-deficient Bombyx mori nucleopolyhedrovirus (BmNPV-CP − -Chi − ) bacmid. The expressed α2,6-SiaT and commercially available α2,3-SiaT were used for sialylation of asialoglycopolypeptides (7-9). The structure-activity relationship of the resulting α2,3 6-sialoglycopolypeptides (10-15) with different glycans in the array has been investigated by focus-forming and solid-phase binding assays. The avian viruses specifically bound to glycopolypeptides carrying a short sialo-glycan with higher affinity than to a long glycan. In contrast, human viruses preferentially bound to long α2,3 6 sialylated glycan with LacNAc repeats in the receptors. Our strategy provides a facile way to design strong polymeric inhibitors of infection by avian and human influenza viruses.
Influenza viruses infect host cells through the binding of viral hemagglutinins (HAs) to sialoglycoproteins or sialoglycopeptides of the receptors on the host cell surfaces. 1 3) Because the molecular recognition process leads to the adhesion of host cell and virus, molecules having a high affinity for the viral HA act as potent inhibitors of infection by influenza viruses. 4 6) Host cell specificity of the virus is dependent not only on linkage of sialic acids (SAs) to the penultimate galactose but also on the number of SA residues and the precise nature of the core structure. 7 11) The recognition ability of glycol signals is also known to be greatly enhanced by clustering the sialooligosaccharides on macromolecular scaffolds such as the synthetic glycopolymers. 6,12 16) The multivalent interactions have been amplified by the so called glycoside cluster effects. 17) Various factors are known to influence the affinity and specificity of multivalent binding events including the structure of the individual saccharide residues. 8 10) In this respect, a variety of synthetic glycopolymers carrying multivalent sialooligosaccharides that target HAs have been produced for influenza virus inhibitors using polyacrylamide, 17 22) poly(acrylacid), 14, 23) polystyrene 12) and dendrimers 24) as the polymer backbone. However, synthetic glycopolymers potentially pose several problems for in vivo use, such as low solubility, significant cytotoxicity and immunogenicity. We have already reported that sialoglycopolypeptides with α or γ PGA backbones can be used as a scaffold in the synthesis of multivalent inhibitors of the influenza viruses. 6, 9, 16) Glycopolypeptides possessing either multivalent SAα2,3Gal or SAα2,6Gal have aided our understanding of human adaptation of the H5N1 influenza virus.
9) The length of the asialo portion in glycopolypeptides also increased binding affinity to the viral HA in a glycan length dependent manner. 8) Recent studies using co crystal structures with glycan microarrays also showed that human viral HAs specifically bound to long α2,6 sialylated glycans with a length beyond trisaccharide, whereas avian viral HAs bound to short α2,3 sialylated glycans. 25) These findings indicate that glycan length of the receptors is another determinant of human viral HAs binding to the terminal α2,6 linked sialoside in the core glycan structures.
Thus far in these macromolecular approaches, the use of ligands has been limited to small carbohydrate units containing sialodi or sialotrisaccharide. Spatial arrange- Using these glycopolymers, the structure activity relationship was elucidated by measurement of the inhibition of infection by avian and human influenza viruses. 26) Convenient synthetic route to a new type of artificial glycopolymer. We designed a series of glycopolypeptides consisting of three parts: glycan, spacer, and polypeptide backbone. Figures 1 and 2 represent the pathway via the following three steps.
1 ) Enzymatic synthesis of oligosaccharide glycosides carrying LacNAc repeats. Recently, we found that endo β glycosidase, a kind of cellulase from Trichoderma reesei, catalyzes two types of reaction, transglycosylation and condensation. 29) Thus, this enzymatic catalysis was harnessed for the present synthesis of spacer linked trifluoroacetamidoalkyl N acetyllactosaminyl glycoside. A condensation reaction between LacNAc and 5 trifluoroacetamido 1 pentanol was performed using a partially purified enzyme preparation from T. reesei. 29) The molar ratio of LacNAc to 5 trifluoroacetamido 1 pentanol was 1 : 1.5, and the total substrate concentration in the reaction mixture was 70% (w v). The reaction mixture was easily fractionated with a charcoal celite column. The target 5 trifluoroacetamidopentyl β N acetyllactosaminide (1) was obtained in a low yield of 1.1% based on the initial amount of LacNAc. The efficiency of the reaction is not always high, but this method has two advantages: first, the excess of unreacted LacNAc substrate, which is a valuable substrate, is recovered by straightforward column chromatography and can be reutilized for synthesis; and second, the O glycosidation process stereospecifically gives only the β glycoside without the need for any protection or deprotection steps. Next, O linked oligosaccharide glycosides carrying LacNAc repeats were then derived from 1 ( Fig. 1) . Thus, consecutive additions of β1,3 linked GlcNAc and β1,4 linked Gal to respective 1 acceptor led to the synthesis of tetrasaccharide glycoside 2 carrying tandem LacNAc repeats by using either β3GnTII or β4GalTI. GlcNAc and Gal residues can then be added to the resulting glycoside 2 in a similar way to form hexasaccharide glycoside 3 carrying triplet LacNAc repeats. The target products 2 and 3 were obtained in high yields of 72 and 85%, respectively, based on the acceptors.
2 ) Synthesis of asialoglycopolypeptides. The resulting oligosaccharide glycosides with different glycans in the array were similarly deacylated to the corresponding amino group by alkali treatment as mentioned above (Fig. 2) . The amino function of the resulting oligosaccharide glycosides 4 6 were reacted with the carboxy groups of γ PGA in the presence of the condensation reagents BOP and HOBt, as described earlier.
In the synthesis, γ PGA of 990 kDa was used as the polypeptide base of the glycopolymers. The reaction solution was applied to a column of Sephadex G 25M PD 10 to separate the glycosylated γ PGA from the low molecular weight reactants. The degree of substitution (DS) in mole fraction of the substituted residues in the asialoglycopolypeptides 7 9 was calculated by two methods: 1 H-NMR and chemical analyses. The 1 H-NMR results were based on the relative intensities of signals due to peptide methylene protons and those due to spacer linked methylene protons in the aglycon. The chemical analysis procedure used the method of Yasuno et al. 30) The DS in those asialoglycopolypeptides was limited to the extent of 40 50% by controlling the coupling conditions of the aminated spacer linked glycosides with γ PGAs (Tables 1 and 2). 3 ) Production of a rat recombinant α2,6 SiaT using Bombyx mori and its utilization for sialylation of asialoglycopolypeptides. In order to synthesize an artificial sialoglycopolypeptide, we developed a large scale production of rat α2,6 SiaT. 28) Functional rat recombinant α2, 6 SiaT was expressed using a bacmid system. The amount of recombinant protein secreted from silkworm larvae was 2.0 U mL (Fig. 3) , which was higher than that obtained from other expression systems. 31 33) In addition, we produced various N terminal tagged α2,6 SiaTs using our silkworm expression system. FLAG tagged α2, 6 SiaT had a high expression level, which was 4.1 fold higher than that of His tagged α2,6 SiaT (Fig. 3) . Some investigators have reported an increase of expression levels of recombinant proteins when N terminal sequences were changed. 34 36) Most likely, the polar character of the N terminal sequence is contributing to the expression level of recombinant protein secreted from silkworm larvae. The expressed FLAG tagged α2,6 SiaT was effectively purified by precipitation with ammonium sulfate followed by affinity chromatography (Fig. 4) . The amount of the protein reached 200 µg larva (Table 3) . This highly purified enzyme might be used for studies such as NMR or X ray 
e Degree of substitution of sugar derivatives based on DP of γ PGA as 100%. Calculated from 1 H-NMR data at 25 C. Degree of substitution of asialo or sialo sugar derivatives based on DP of γ PGA as 100%. Calculated from two type HPLC analyses (ABEE and DMB methods). (All data normalized to those of 1 H-NMR.). Three type BmNPV bacmids were injected directly into 1st day of fifth instar silkworm larvae. The expression of the fusion protein in silkworm larvae was confirmed using a sialyltransferase activity assay.
diffraction. Recombinant protein produced by BmNPV
SiaT with bx signal peptide infected silkworm was comparable to native rat liver α2, 6 SiaT with regard to substrate specificity and stability. FLAG tagged α2,6 SiaT lacks a N terminal hydrophobic region found in the wild type protein, as previously reported by Weinstein et al. 37) The Km of the purified recombinant enzyme (0.92 mM) against 5 [5 dimetylaminonaphthalene 1 sulfonyl 2 ( 2 aminoethoxy ) ] ethyl β LacNAc was similar to that rat liver α2,6 SiaT (Table 4) . 38) The expressed α2,6 SiaT was used for sialylation of asialoglycopolypeptides.
Finally, a series of asialoglycopolypeptides with different glycans (7 9) in the array were sialylated to 13 15 carrying SAα2,6Gal by using recombinant FLAG tagged α2,6 SiaTs prepared above (Fig. 2) . After separation through a column of Sephadex G 25M PD 10, the target glycopolypeptides were obtained. Asialoglycopolypeptides (7 9) were also in a similar manner sialylated to 10 12 carrying SAα2,3Gal by commercially available α2,3 SiaT. The structures of the synthesized glycopolymers were confirmed by 1 H and 13 C NMR analyses. The DS of sialyl sugar derivatives in the sialoglycopolypeptides was determined by 1 proton. It was possible to evaluate the extent of sialylation from the integration data of the resulting proton signals ( Table 2 ). The properties of the synthesized glycopolypeptides are summarized in Table 2 . The chemical analysis was performed using the method of Sato et al. 39) The degree of substitution of neutral sugar derivatives (NS) and sialyl sugar derivatives (Sia) was based on the DP of γ PGA, which was arbitrarily given a value of 100% (Table 2 ). In the 13 C NMR spectra of 12 and 15, the respective C 3 and C 6 signals were distinguished by a downfield position with chemical shifts at δ 78.0 and δ 66.2. These data indicate that the terminal Gal residues of the sugar chains are regiospecifically sialylated in the α2 3 and α2 6 linkages. The recombinant α2, 6 SiaT from a silkworm expression system is useful for the sialylation of asialoglycopolypeptides. As a result, sialylation of the asialo portion of the glycopolymers was almost quantitative at around 40%, whose proportion is based on the optimum result on inhibition of viral infection ( Table 2) .
Interaction of synthetic glycopolypeptides with influenza viruses.
To date, infections by influenza viruses have been successively inhibited by sialoglycopolymers carrying short glycans, such as sialyllactose and sialyl LacNAc, no matter how short the glycan chain. 12) However, recent studies including ours have demonstrated that the length of the glycan beyond a trisaccharide critically influences viral HA binding contacts. 9, 11, 25, 40) In the present study, the contribution of the asialo portion in the sugar chains was examined by focus forming and solid phase binding assays using glycopolypeptides carrying different lengths of glycan in the array. Five strains of avian and human influenza viruses were used as models for studies aimed at identifying the HA glycan binding specificity. First, the focus forming assay confirmed that artificial glycopolypeptide effectively inhibited cellular infection by One unit of activity is defined as 1 µmol min of transfer product formed with LacNAc dansyl as acceptor substrate in 37 C, pH 7.4. Enzyme activities were determined by HPLC based assay described in Ref. 28 ).
avian and human strains ( Table 5 ). The avian viruses specifically recognized a short α2,3 sialylated glycan to an LacNAc motif in a trisaccharide. Compound 10, carrying a short glycan of trisaccharide, showed 4 10 fold higher inhibitory activity than 12 carrying triplet LacNAc repeats. In addition, the virus did not bind to the terminal SA linked α2,6 of the LacNAc motif. In contrast, the human virus A WSN 33 (H1N1) was inhibited by glycopolymers carrying a long α2,3 6 sialylated glycan with LacNAc repeats. The inhibition clearly occurred in a glycan length dependent manner. Viral infection was strongly inhibited by 12 and 15 carrying long glycans at a very low concentration (IC50 0.06 pM). Inhibition by 12 displayed 13 × 10 6 fold higher activity compared to that of 10, which carries a short glycan. In this case, the sugar elongation of the inner glycan for 12 resulted in a remarkable increase of inhibition activity to enhance the virus binding. The human virus, A Aichi 2 68 (H3N2), which has high susceptibility to compounds 14 and 15 (IC50 0.1 0.2 pM), also showed a similar pattern of inhibitory effect. Taken together, our results indicate that the length of the sialylated glycan critically influences binding to the human virus, which is favored by long glycan units such as LacNAc repeats. These results were further supported by solid phase binding assays which showed that elongation of core carbohydrate portion markedly enhances binding affinity of α2,3 6 sialopolymers with the human viral HA (Fig. 5) . A possible explanation could lie with the difference in the conformation of the terminal trisaccharides resulting from sialic acid linkage in the co crystal structures. 25, 40) Chandrasekaran et al . have proposed that the cone like and umbrella like topologies are governed by conformation of the α2,3 and α2,6 sialylated trisaccharides, respectively. 25) In the umbrella like topology, longer α2,6 oligosaccharides (at least pentasaccharide residues) favor this conformation. 25) Thus, in the umbrella like topology, which is unique to α2,6, the specificity for a kink motif at least five sugar residues long could indicate that a kinked sugar chain of comparable residues is able to reach into the binding locus on the HA surface. This concept was also the case for the present viral HA binding. Therefore, whereas the avian viral HA interactions with the glycans is characteristic of short α2,3 glycans, such as single LacNAc, human viral HA interactions involve α2,6 and are typically adopted by long glycans with multiple repeating LacNAc units. Infection and binding experiments clearly showed that the extended structure of the glycan enhanced the inhibitory activity. Furthermore, γ PGA is an obvious starting point to prepare polymeric inhibitors because it is a readily available and inexpensive polymer. Indeed, the γ PGA backbone from B. subtilis is commercially available in large quantities. The physiological merits of α and γ PGAs as the backbone to a glycopolymer in terms of cytotoxicity and immunogenicity have already been investigated. We have demonstrated that sialoglycopolymers with a α PGA backbone have relatively low immunogenicity. 16) Generally, conventional glycopolymers with a backbone such as PA can be toxic. 17, 20) In our previous study, acrylamide monomer, which is known to be a potent neurotoxin, and PAA Na were found to be cytotoxic to MDCK cells under the con- ditions used for the tests.
16) It has also been shown that sugar bovine serum albumin (BSA) and PA conjugates act as antigens or immunogens. 16) 
Conclusion.
Artificial sialoglycopolymers with a γ PGA backbone that possess a single type of SA linkage (either α2,3 or α2,6) were chemoenzymatically synthesized. These compounds were then used as a tool to study the molecular interactions between receptors and viruses. It should be emphasized that our PGA based polymers have an extremely high solubility in water (>10% w v), as compared with PA based polymers (1<%), and that they are remarkably heat stable with no aggregation, even in boiling water. Therefore, PGA based glycopolymers have ideal characteristics as potential in vivo polymeric inhibitors. Furthermore, precise analysis of the asialo moiety in the array of glycopolypeptides provides a facile way to explore the role of the glycan sequence in the binding of glycopolymers to the viruses, as well as increasing our understanding of the molecular basis to infection by influenza virus. 
